Medtronic, Inc. has initiated 4 medical device notifications about the SynchroMed Implantable Infusion System, the US Food and Drug Administration (FDA) announced June 28. The FDA reports that 3 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results